6 Results for "

U2 snRNP

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "U2 snRNP" in MCE Product Catalog:

Cat. No.: HY-153736
CAS No.: 90379-42-3
Purity:  98.40%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

NSC 194308, a U2AF2-RNA complexes enhancer, increases association of the U2AF1-U2AF2-SF1-splice site RNA complex by binding a site between the U2AF2 RNA recognition motifs (RRM1 and RRM2). NSC 194308 inhibits pre-mRNA splicing by stalling spliceosome assembly at the point where U2AF helps recruit U2 snRNP to the branchpoint. NSC 194308 enhances the binding of pre-mRNA to U2AF2, selectively triggering cell death in leukemia cell lines containing spliceosome mutations .
loading...
    loading...
Cat. No.: HY-133924
CAS No.: 1200128-66-0
Synonyms: RQN-18690A
Target:  

SF3B1

Research Areas:  

Cardiovascular Disease Cancer

18-Deoxyherboxidiene (RQN-18690A) is a potent angiogenesis inhibitor. 18-Deoxyherboxidiene targets SF3b, a spliceosome component that is a subcomplex of the U2 small nuclear ribonucleoprotein (snRNP) in the spliceosome. 18-Deoxyherboxidiene inhibits the migration and tube formation of human umbilical vein endothelial cells (HUVECs) without significant cell toxicity. 18-Deoxyherboxidiene has the potential for cancer research .
loading...
    loading...
Cat. No.: HY-120907
CAS No.: 1197054-49-1
Target:  

SF3B1

Research Areas:  

Cancer

Sudemycin E is an analog of FR901464 (HY-16212). Sudemycin E can induce reversible changes in alternative splicing and abnormalities in chromatin modifications by binding to SF3B1, a component of the U2 small nuclear ribonucleoprotein (snRNP), thereby leading to the death of cancer cells. Sudemycin E has anti-tumor activity and can be used in tumor research .
loading...
    loading...
Cat. No.: HY-122637
CAS No.: 2071636-70-7
Target:  

SF3B1

Research Areas:  

Cancer

Sudemycin K is a selective splicing inhibitor targeting SF3B1. Sudemycin K blocks U2 snRNP recognition of branch point sequences in pre-mRNA, inducing tumor-specific splicing deregulation and apoptosis. Sudemycin K is promising for research of SF3B1-mutated malignancies such as chronic lymphocytic leukemia (CLL) and myelodysplastic syndromes (MDS) .
loading...
    loading...
Cat. No.: HY-P87080
Synonyms: Lea1 antibody; RU2A_HUMAN antibody; Small nuclear ribonucleoprotein polypeptide A antibody; SNRPA1 antibody; U2 small nuclear ribonucleoprotein A'' antibody; U2 small nuclear ribonucleoprotein polypeptide A' antibody; U2 snRNP A antibody; U2 snRNP A'' antibody;

Host:  

Rabbit

Application:  

WB, ICC/IF, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P703295
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: U2AF2; U2AF65; U2 snRNP Auxiliary Factor Large Subunit; U2 Small Nuclear RNA Auxiliary Factor 2; Splicing factor U2AF 65 kDa subunit; U2 auxiliary factor 65 kDa subunit; hU2AF65; hU2AF65; U2 snRNP auxiliary factor large subunit; DEVDFB; HU2AF(65); Splicin
Species:  
Source:  
loading...
    loading...